Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

484 ARTÍCULOS , VIENDO DEL 16 AL 30

Individualized repetitive intravenous immunoglobulin therapy for a 79-year-old patient with GlyR antibody-positive PERM: a case report and literature review

Liu X, Zhu J, Lei Y, Yu X, Mi X.

Front Immunol. 2026 Jul 7;17:1867563. doi: 10.3389/fimmu.2026.1867563. eCollection 2026.

[Clinical spectrum, neuroimaging and therapeutic response to neurological syndromes associated with anti-GAD65]

Hernández-Salomón LF, Sánchez-Galván DMS, Galván-Heredia P, Mejía-Chávez JA, Solís-Luna SM, Aguayo Jiménez CE.

Rev Med Inst Mex Seguro Soc. 2026 Jul 13;64(4):e6817. doi: 10.5281/zenodo.19076356.

Case report: Thymoma-associated GAD65 autoimmunity: a unifying mechanism for multi-organ injury involving nervous, endocrine, and renal systems

Sun J, Sun S, Sun Z, Huang Q, Luo L.

Front Immunol. 2026 Mar 12;17:1790631. doi: 10.3389/fimmu.2026.1790631. eCollection 2026.

Progressive Muscle Rigidity and Spasms in an Older Adult: A Diagnostic Challenge

Leonard SD, Tran HT.

Cureus. 2026 Apr 2;18(4):e106329. doi: 10.7759/cureus.106329. eCollection 2026 Apr.

Diagnostic Ambiguity of Encephalopathy in Advanced Kidney Disease: Multisystem Overlap in a Patient With Autosomal Dominant Polycystic Kidney Disease (ADPKD), Heart Failure, and Stiff Person Syndrome

Ahmad CM, Kastle RA, Agarwal I, Elliott-Ventura S, Farooq M.

Cureus. 2026 Apr 1;18(4):e106269. doi: 10.7759/cureus.106269. eCollection 2026 Apr.

CAR T-Cell Therapy in Neurology: A Scoping Review of Neuro-Oncology, Autoimmune Diseases & Neurotoxicity

Alqaisi O, Dibas M, Tai P, Dibas A, Souied O, Al-Ghabeesh S.

Ann Clin Transl Neurol. 2026 Apr 27. doi: 10.1002/acn3.70415. Online ahead of print.

Sjögren's Disease and Stiff Person Syndrome: A case series highlighting a rare but significant autoimmune overlap

Alkhatib A, Jabari D, Noaiseh G.

Clin Rheumatol. 2026 May;45(5):2943-2948. doi: 10.1007/s10067-026-08008-y. Epub 2026 Feb 27.

Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission

Moodley K.

J Neuroimmunol. 2026 Jun;415:578891. doi: 10.1016/j.jneuroim.2026.578891. Epub 2026 Feb 16.

Cellular therapies in autoimmune neuromuscular disorders: the new frontier

Habib AA, Villalta SA, Pratap S, Mozaffar T.

Neuromuscul Disord. 2026 Jun;63:106408. doi: 10.1016/j.nmd.2026.106408. Epub 2026 Mar 11.

Aggravation of stiff-person syndrome with ophthalmoplegia after tandospirone initiation: a case report

Yang K, Chen W, Tang Y, Chang S, Sun R, Lv P, Dong Y.

Front Immunol. 2026 Apr 2;17:1749793. doi: 10.3389/fimmu.2026.1749793. eCollection 2026.

Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS neurologic diseases

Stathopoulos P, Dalakas MC.

Handb Clin Neurol. 2026;214:47-64. doi: 10.1016/B978-0-323-90887-0.00003-1.

The prospects of CAR T-cell therapies in changing the therapeutic algorithm of neurologic autoimmunities

Dalakas MC.

Ther Adv Neurol Disord. 2026 Mar 16;19:17562864261429570. doi: 10.1177/17562864261429570. eCollection 2026.

Stiff-person syndrome with concurrent Graves disease: a rare autoimmune overlap

Rayan MN, Alshawabkeh Y, Irvathraya V, O'Donnell B.

JCEM Case Rep. 2026 Mar 24;4(4):luag058. doi: 10.1210/jcemcr/luag058. eCollection 2026 Apr.

Anti-amphiphysin antibody positive autoimmune syndrome: case series and literature review

Wang L, Chen J, Tang X, Yu H, Guo D, Chen X, Cao L, Lu K.

Front Immunol. 2026 Apr 1;17:1782004. doi: 10.3389/fimmu.2026.1782004. eCollection 2026.

CAR T cell therapy in autoantibody-mediated neurological disorders: a promising strategy

Wen M, Zheng R, Zhang H, Goldberg SY, Jian Z, Gao Y, Cheng R, Wen L, Zhao Y, Kenderian SS, Shang P.

J Neuroinflammation. 2026 Mar 12;23(1):85. doi: 10.1186/s12974-025-03662-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias